Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval
Go back to Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval| Agilent Technologies Inc (NYSE: A) | Delayed: 148.45 -0.08 (0.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $148.53 | 52 Week High | $48.63 | |||
| Open | $147.81 | 52 Week Low | $34.15 | |||
| Day High | $149.12 | P/E | 68.73 | |||
| Day Low | $147.19 | EPS | $2.16 | |||
| Volume | 964,636 | |||||
| (NASDAQ: AUTL) | Delayed: 2.28 +0.13 (6.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.15 | 52 Week High | $ | |||
| Open | $2.15 | 52 Week Low | $ | |||
| Day High | $2.33 | P/E | N/A | |||
| Day Low | $2.13 | EPS | $ | |||
| Volume | 3,031,952 | |||||
